Pascale Boissel
Net worth: 1 852 $ as of 30/06/2026
Net worth: 1 852 $ as of 30/06/2026
Ms. Pascale Boissel is an Independent Member-Supervisory Board at Innate Pharma SA and an Independent Non-Executive Director at Sartorius Stedim Biotech SA. She is on the Board of Directors at Innate Pharma SA and Sartorius Stedim Biotech SA. Ms. Boissel was previously employed as a CFO, Director-Finance & Administration by ENYO Pharma SA, a Chief Financial Officer by Novadiscovery SA, an Independent Director by Poxel SA, a Director-Finance & Administration & Deputy CEO by BioAster, and a Chief Financial Officer & Head-Media Relations by Ipsogen SA. She received her undergraduate degree from École des Hautes Études Commerciales de Paris and an MBA from École des Hautes Études Commerciales de Paris.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2026 | 1,000 ( 0% ) | 1 852 $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| SARTORIUS STEDIM BIOTECH | Director/Board Member | 26/03/2019 |
| INNATE PHARMA | Director/Board Member | 19/05/2020 |
| Companies | Position | End |
|---|---|---|
Novadiscovery SAS
Novadiscovery SAS Information Technology ServicesTechnology Services Operates as a health technology company | Director of Finance/CFO | 01/01/2021 |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Director of Finance/CFO | 01/05/2018 |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services Operates as a research institute | Director of Finance/CFO | 01/12/2016 |
| QIAGEN MARSEILLE | Director of Finance/CFO | 01/01/2012 |
| POXEL | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Poxel SA
Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
École des Hautes Études Commerciales de Paris
École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA Medical SpecialtiesHealth Technology Manufactures and supplies biopharmaceutical products and medical equipment | Health Technology |
QIAGEN Marseille SA
QIAGEN Marseille SA Miscellaneous Commercial ServicesCommercial Services Develops and markets molecular diagnostic tests for cancer | Commercial Services |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services Operates as a research institute | Commercial Services |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Novadiscovery SAS
Novadiscovery SAS Information Technology ServicesTechnology Services Operates as a health technology company | Technology Services |
Select your edition
All financial news and data tailored to specific country editions